41.510
41.51 (0%)
As of Dec 20, 2024
Mirum Pharmaceuticals, Inc. [MIRM]
Source:
Company Overview
Mirum Pharmaceuticals, Inc is a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases. We have three approved medicines: Livmarli, Cholbam, and Chenodal.
| Country | United States |
| Headquarters | foster city, california |
| Phone Number | (650) 667-4085 |
| Industry | manufacturing |
| CEO | Christopher Peetz |
| Website | www.mirumpharma.com |